Company Financials

Verona Pharma plc Financials

Indonesian rupiah

business Verona Pharma plc Company Profile

Main Stock Listing

NASDAQ: VRNA

Market Capitalization $7.78 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 129.17
Forward PE
Price to Sales TTM Rp3.18
Price to Book MRQ Rp0.68
Enterprise to Revenue 16.80
Enterprise to EBITDA

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2024-12-31
Profit Margin -7.84%
Operating Margin 9.66%
Return on Assets TTM -0.40%
Return on Equity TTM -1.66%

Income Statement

Revenue TTM Rp158,924,914,688
Revenue per Share TTM Rp27.94
Quarterly Revenue Growth 89.40%
Gross Profit TTM Rp154,044,383,232
EBITDA Rp0
Net Income to Common TTM Rp-12,454,676,480
Diluted EPS TTM Rp0.69
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ Rp54,141,755,392
Total Cash per Share MRQ Rp9.52
Total Debt MRQ Rp
Total Debt to Equity MRQ 299.55
Current Ratio MRQ 1.49
Book Value per Share MRQ Rp130.21

Cash Flow

Operating Cash Flow TTM Rp64,874,553,344
Levered Free Cash Flow TTM Rp0

VRNA Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 5,687,353,997
Float Shares 426,551,550
Avg 10 Volume 2,542,370
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 92.50%
% Held by Institutions 0.17%

Stock Price Summary

Beta -0.19
Fifty Two Week Low Rp68.00
Fifty Two Week High Rp120.00
Fifty Two Week Change 2.25%
Day 50 MA Rp86.52
Day 200 MA Rp82.14

Dividends and Splits

Forward Annual Dividend Rate Rp
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate Rp0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio %
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date